Similar articles

• Management of patients with head and neck tumours presenting at diagnosis with a synchronous second cancer at another anatomic site.

  Graff P, Schipman B, Desandes E, Mecellem H, Toussaint B, Cortese S, Marchal F, Kaminsky MC, Geoffrois L, Peiffert D. Graff P, et al. Clin Oncol (R Coll Radiol). 2011 Apr;23(3):174-81. doi: 10.1016/j.clon.2010.10.008. Epub 2010 Dec 3. Clin Oncol (R Coll Radiol). 2011. PMID: 21130631
• Long-term results of the combined modality therapy for advanced cervical metastatic head and neck squamous cell carcinoma.

  Preuss SF, Klussmann JP, Wittekindt C, Damm M, Semrau R, Drebber U, Guntinas-Lichius O. Preuss SF, et al. Eur J Surg Oncol. 2007 Apr;33(3):358-63. doi: 10.1016/j.ejso.2006.10.043. Epub 2006 Dec 8. Eur J Surg Oncol. 2007. PMID: 17157472
• Organ preservation: II.

  Hanna EY. Hanna EY. Curr Oncol Rep. 2001 Jan;3(1):44. Curr Oncol Rep. 2001. PMID: 15849884 Clinical Trial. No abstract available.
• [Development, current status and perspectives of tumor therapy in oromandibulofacial surgery--a determination of the current status].

  Hausamen JE, Eckardt A, Schmelzeisen R. Hausamen JE, et al. Fortschr Kiefer Gesichtschir. 1994;39:5-12. Fortschr Kiefer Gesichtschir. 1994. PMID: 8088670 Review. German. No abstract available.
• Cervical lymphatics and squamous cell carcinoma of the head and neck: biologic significance and therapeutic considerations.

  Carlson GW. Carlson GW. Surg Oncol Clin N Am. 1996 Jan;5(1):65-77. Surg Oncol Clin N Am. 1996. PMID: 8789494 Review. No abstract available.